Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

Blood sample collection | Image credit: luchschenF - stock.adobe.com
High Soluble Klotho Levels Linked to Lower CKD Prevalence in Adults With Diabetes, Hypertension

May 6th 2025

New research reveals how serum soluble Klotho levels relate to chronic kidney disease risk (CKD) in patients with diabetes and hypertension.

Image credit: Pharmacy_Karanov images - stock.adobe.com
SGLT2s, GLP-1s, Finerenone Have Unique Benefits in CKD, Diabetes: Meta-Analysis

April 25th 2025

Patient telling physician about his pain and health problems during visit to hospital. Young African-American man complaining about back ache while sitting on examination bed at the doctor's - Studio Romantic - stock.adobe.com.jpeg
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment

April 21st 2025

Center on Health Equity and Access
Health Equity & Access Weekly Roundup: April 21, 2025

April 21st 2025

Image credit: health care costs - Nuttapong punna
Cost-Effectiveness Analysis: CKD Screening, SGLT2 Inhibitors Can Reduce Kidney Failure Risk, Racial Disparities

April 18th 2025

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

Dapagliflozin Gets Breakthrough Therapy Designation for CKD
October 2nd 2020

Dapagliflozin Gets Breakthrough Therapy Designation for CKD

Mary Caffrey
The FDA action follows presentation of results in August during the European Society of Cardiology 2020 Virtual Congress.
New VERTIS-CV Analysis Finds Renal Benefits for Ertugliflozin on Par With Other SGLT2s
September 29th 2020

New VERTIS-CV Analysis Finds Renal Benefits for Ertugliflozin on Par With Other SGLT2s

Mary Caffrey
A new analysis shows that ertugliflozin matched renal results seen in trials for a pair of rival sodium glucose cotransporter 2 (SGLT2) inhibitors.
ESMO
September 21st 2020

Combo for Metastatic Kidney Cancer Cuts Death Risk 40%

AJMC Staff
Nivolumab, a checkpoint inhibitor, and cabozantinib, a targeted therapy, produced dramatic results when used in combination for patients with newly diagnosed advanced kidney cancer.
kidney
September 20th 2020

Reducing Urinary Protein Improves Survival for Patients With Rare Kidney Disease

Mary Caffrey
Researchers suggest that clinical trial design could be shaped by measuring reductions in urinary protein.
HHS Secretary Alex Azar
September 18th 2020

CMS Finalizes Kidney Care Model to Promote Home Dialysis, Live Donor Transplants

Mary Caffrey
Trump administration officials said the new payment incentives represent the biggest change in kidney care in decades.
Thyroid, Kidney Cancer on Rise Among Adolescents and Young Adults
September 18th 2020

Thyroid, Kidney Cancer on Rise Among Adolescents and Young Adults

Mary Caffrey
Kidney cancer rose at least 3% a year during the years studied among adolescents and young adults, according to data from the American Cancer Society.
Oral Treatment for Renal Anemia Draws Attention From Congress
September 10th 2020

Oral Treatment for Renal Anemia Draws Attention From Congress

Mary Caffrey
Members of Congress introduce a bill to force Medicare to cover a drug they say will protect CKD patients during the COVID-19 pandemic.
cardiac rehab
September 10th 2020

For Renal Function, Cardiac Rehab Provides the Most Benefit to Those Who Most Need It

AJMC Staff
A study suggests cardiac rehabilitation offers the most benefits to patients who start out with more advanced renal disease.
Dr Milton Packer Highlights Renal Outcomes of EMPEROR Reduced
September 5th 2020

Dr Milton Packer Highlights Renal Outcomes of EMPEROR Reduced

In the past 30 years, we've never seen a heart failure drug that has had such a beneficial effect on the kidneys, said Milton Packer, MD, a distinguished scholar in cardiovascular science at Baylor University Medical Center in Dallas, and chair of the department of clinical sciences at the University of Texas Southwestern Medical School.
kidney care
September 4th 2020

From Clinical Trial to Clinical Practice: How Can DAPA-CKD Lead to Prevention in Renal Care?

Mary Caffrey
Kidney failure is one of the expensive conditions in health care, but new results from the DAPA-CKD trial could change the equation in favor of prevention.
kidney with PKD
August 27th 2020

Study on Genetic Testing for Kidney Disease in Embryos Highlights Access, Coverage Issues

Mary Caffrey
A Dutch study shows how genetic testing can help couples avoid passing devastating kidney diseases to their children, but it raises issues of disparities.
AI
August 23rd 2020

AstraZeneca, RenalytixAI Announce Collaboration in Cardiovascular, Renal, and Metabolic Disease

AJMC Staff
A proprietary algorithm can help payers identify patients at high risk of progressive chronic kidney disease.
Tobias Huber
August 19th 2020

Lancet: COVID-19 Virus Can Attack Kidneys, Speeding Death

Mary Caffrey
German researchers find viral RNA in kidneys of patients who died from COVID-19.
HHS logo
August 18th 2020

Administration Offers Progress Report on Kidney Care Initiative

Mary Caffrey
An HHS report outlines efforts to reduce kidney failure and increase options such as home-based dialysis. COVID-19 has made kidney care a higher priority.
Contributor: Does Medicare Support Coordinated Care for Those on Dialysis? Actions Speak Louder than Words
August 15th 2020

Contributor: Does Medicare Support Coordinated Care for Those on Dialysis? Actions Speak Louder than Words

LaVarne A. Burton
A new rule makes it impossible for patients with end-stage renal disease (ESRD) to take part in Medicare Advantage, leaving them out of coordinated care.
Research to Examine Renal Failure Associated With Cardiomyopathy
August 12th 2020

Research to Examine Renal Failure Associated With Cardiomyopathy

AJMC Staff
A Marshall University researcher received $444,000 from NIH to continue researching a new treatment target in chronic renal failure.
Contributor: Under New Rule, MA Plans Can Keep a Blindfold on Dialysis Facility Choice for Individuals With Kidney Failure
August 8th 2020

Contributor: Under New Rule, MA Plans Can Keep a Blindfold on Dialysis Facility Choice for Individuals With Kidney Failure

Lori Hartwell
A rule change to let those with end-stage renal disease enroll in Medicare Advantage has a twist that could stop patients from learning if their dialysis center iis in the network.
New Renal, HF Results Seen in 2020 ACC Pathway on CV Risk Reduction
August 5th 2020

New Renal, HF Results Seen in 2020 ACC Pathway on CV Risk Reduction

Mary Caffrey
The American College of Cardiology updates guidance on prescribing SGLT2 inhibitors and GLP-1 receptor agonists to patients with type 2 diabetes and cardiovascular disease or CV risk.
Future Management of Anemia in CKD
August 4th 2020

Future Management of Anemia in CKD

Future Treatment of Anemia in CKD: Impact of HIF Stabilizers
August 4th 2020

Future Treatment of Anemia in CKD: Impact of HIF Stabilizers

Anemia in CKD: HIF Stabilizers in Clinical Trials
August 4th 2020

Anemia in CKD: HIF Stabilizers in Clinical Trials

Payer Perspective of HIF Stabilizers for Anemia in CKD
August 4th 2020

Payer Perspective of HIF Stabilizers for Anemia in CKD

HIF Stabilizers: Management of Anemia in CKD
August 4th 2020

HIF Stabilizers: Management of Anemia in CKD

HIMALAYAS Trial: Long-Term Cardiovascular Safety Data
August 4th 2020

HIMALAYAS Trial: Long-Term Cardiovascular Safety Data

HIF Stabilizers for Anemia in CKD: Phase 3 Trials
August 4th 2020

HIF Stabilizers for Anemia in CKD: Phase 3 Trials

Treatment of Anemia in CKD During COVID-19
August 4th 2020

Treatment of Anemia in CKD During COVID-19

Economic Burden of Anemia in CKD
August 4th 2020

Economic Burden of Anemia in CKD

Anemia in CKD: CHOIR and TREAT Trials
August 4th 2020

Anemia in CKD: CHOIR and TREAT Trials

Standard of Care: Therapeutic Options for Anemia in CKD
August 4th 2020

Standard of Care: Therapeutic Options for Anemia in CKD

Treatment of Anemia in CKD
August 4th 2020

Treatment of Anemia in CKD

<1
...
5678910111213>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo